COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04723550

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose health services research
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Wenwen Yin (from the registry)
Registry
  • NCT NCT04723550
Other papers using this trial's data
  • Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study PloS one, 2022 DOI, PubMed 36174028, PMC9522303 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04723550. Randomized; no masking; primary purpose health services research. Start 2021-01-05 (actual); primary completion 2021-11-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Hospital telemedicine management system
Intervention (Other)
Usual care
Lead sponsor
Wenwen Yin (class: other)

Record details

Record id
cardio:ct-nct04723550
Content hash
fee37493a355d8c151c03afbb4d0a52ce6cc6ab88dd3e013cca93e2e6956dae6